Biochemical analysis of recombinant CYP4A11 allelic variant enzymes: W126R, K276T and S353G
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Songhee | - |
dc.contributor.author | Cha, Gun-Su | - |
dc.contributor.author | Chun, Young-Jin | - |
dc.contributor.author | Lee, Chang Hoon | - |
dc.contributor.author | Kim, Donghak | - |
dc.contributor.author | Yun, Chul-Ho | - |
dc.date.available | 2019-03-08T11:59:47Z | - |
dc.date.issued | 2016-12 | - |
dc.identifier.issn | 1347-4367 | - |
dc.identifier.issn | 1880-0920 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6423 | - |
dc.description.abstract | Human CYP4A11 is the major omega-ehydroxylase of fatty acids in the liver and kidneys. It produces 20-hydroxyeicosatetraenoic acid as well as hydroxylates fatty acids. In this study, we investigated the biochemical properties of three alleles of CYP4A11: W126R, K276T, and S353G. Site-directed mutagenesis of the wild type CYP4A11 was performed, to construct the W126R, K276T, and S353G variant clones. The CYP4A11 wild type and variant constructs were heterologously expressed in Escherichia coli. CO-binding spectra showed the expression of the wild type, K276T and S353G variants, indicating the functional P450 holoenzyme. The W126R variant was not expressed in E. coli. Binding affinities of lauric acid in K276T and S353G variants were stronger than that of wild type. Steady-state kinetics in the hydroxylation reaction of fatty acids were studied. The catalytic efficiencies (k(cat)/K-m) of K276T and S353G variants in the reactions without cytochrome b(5) were approximately 2- and 4-fold higher, respectively, than that of wild type, and in the reactions with cytochrome b5 they were approximately 2- and 3-fold higher, respectively. These results suggest that individuals carrying the alleles, K276T and S353G, might exhibit higher catalysis of CYP4A11, which may affect the endogenous metabolic products associated with regulation of blood pressure. (C) 2016 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | JAPANESE SOC STUDY XENOBIOTICS | - |
dc.title | Biochemical analysis of recombinant CYP4A11 allelic variant enzymes: W126R, K276T and S353G | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.dmpk.2016.09.003 | - |
dc.identifier.bibliographicCitation | DRUG METABOLISM AND PHARMACOKINETICS, v.31, no.6, pp 445 - 450 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000393190700007 | - |
dc.identifier.scopusid | 2-s2.0-84994123708 | - |
dc.citation.endPage | 450 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 445 | - |
dc.citation.title | DRUG METABOLISM AND PHARMACOKINETICS | - |
dc.citation.volume | 31 | - |
dc.type.docType | Article | - |
dc.publisher.location | 일본 | - |
dc.subject.keywordAuthor | P450 | - |
dc.subject.keywordAuthor | CYP4A11 | - |
dc.subject.keywordAuthor | Allele | - |
dc.subject.keywordAuthor | Fatty acid hydroxylase | - |
dc.subject.keywordAuthor | Polymorphism | - |
dc.subject.keywordPlus | HUMAN CYTOCHROME-P450 4A11 | - |
dc.subject.keywordPlus | 20-HYDROXYEICOSATETRAENOIC ACID | - |
dc.subject.keywordPlus | FUNCTIONAL-CHARACTERIZATION | - |
dc.subject.keywordPlus | ESSENTIAL-HYPERTENSION | - |
dc.subject.keywordPlus | T8590C POLYMORPHISM | - |
dc.subject.keywordPlus | 1A2 | - |
dc.subject.keywordPlus | HYDROXYLATION | - |
dc.subject.keywordPlus | HEME | - |
dc.subject.keywordPlus | GENE | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.